Ceftazidime Kabi

Ceftazidime Kabi is a 3^rd generation cephalosporin antibiotic. 

• Broad spectrum cephalosporin antibiotic
• Indicated in severe Pseudomonas aeruginosa infections – even in cystic fibrosis
• Colour coded vials for the different strengths

Ceftazidime Kabi is indicated for the treatment of single or multiple infections caused by susceptible organisms.

May be used alone as first choice drug before the results of sensitivity tests are available.

May be used in combination with an aminoglycoside or most other beta-lactam antibiotics. 

May be used with an antibiotic against anaerobes when the presence of Bacteroides fragilis is suspected.

Susceptibility to ceftazidime will vary with geography and time and local susceptibility data should be consulted where available.

Indications include: 
•    Severe infections e.g.
     -    Septicaemia, bacteraemia, peritonitis, meningitis
     -    Infections in immunosuppressed patients 
     -    Infections in patients in intensive care, e.g. infected burns
•    Respiratory tract infections including lung infections in cystic fibrosis
•    Ear, nose, throat and urinary tract infections
•    Skin and soft tissue infections
•    Gastrointestinal, biliary and abdominal infections
•    Bone and joint infections
•    Infections associated with haemo- and peritoneal dialysis and with continuous ambulatory peritoneal dialysis (CAPD)
•    Prophylaxis: prostatic surgery (transurethral resection)

* Not all pack sizes may be marketed or available locally.
* Product images are for illustration purposes only.

Please note that this product may not be available in all countries due to different registration status. Additionally, approved indications, contraindications, side effects, warnings and all other product characteristics may differ between countries.

If you require any information, please contact your local organization.